JPMorgan Chase's Anthony Chan says now U.S. investors can focus on more important things.
Greece’s debt deal will bode well for stocks, according to JPMorgan (JPM) Chase’s chief economist Anthony Chan.
California company OncoMed is taking its business of developing drugs that target cancer stem cells public.
Emerging markets' demand, coupled with healthy dividends, boost drugmakers.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.